Health and Human Services News and Research

RSS

Study provides evidence that enterovirus may be a factor in acute flaccid myelitis

A new study analyzing samples from patients with and without acute flaccid myelitis provides additional evidence for an association between the rare but often serious condition that causes muscle weakness and paralysis, and infection with non-polio enteroviruses.

13 Aug 2019

Women and older adults at increased risk of dangerous drug interactions

A new study led by researchers at Indiana University has found that women and older adults who use multiple prescription drugs are significantly more likely to be prescribed pills whose combination produces dangerous side effects.

12 Aug 2019

Class-action lawsuit seeks to let Medicare patients appeal gap in nursing home coverage

Medicare paid for Betty Gordon’s knee replacement surgery in March, but the 72-year-old former high school teacher needed a nursing home stay and care at home to recover.

12 Aug 2019

NIH-funded clinical trial will evaluate seasonal influenza vaccines with two experimental adjuvants

An early-stage clinical trial is evaluating two licensed seasonal influenza vaccines, administered with or without novel adjuvants, for their safety and ability to generate an immune response.

9 Aug 2019

Statement related to data inaccuracies with newly approved gene therapy

As a public health agency, we believe that it is critical to facilitate the development of innovative safe and effective medical products, like the cellular and gene therapy products that have shown enormous potential to treat previously untreatable diseases.

7 Aug 2019

Drugmakers now ‘masters’ at rolling out their own generics to stifle competition

When PDL BioPharma's $40 million blood-pressure medicine faced the threat of a generic rival this year, the company pulled out a little-known strategy that critics say helps keep drugs expensive and competition weak.

5 Aug 2019

FDA approves first therapy for symptomatic tenosynovial giant cell tumor

Today, the U.S. Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not responsive to improvement with surgery.

3 Aug 2019

Company expands development plans for drugs which slow progression to dialysis

Kibow Biotech announces that the focus on supporting and maintaining healthy kidney function with probiotics/prebiotics to potentially delay the progression to dialysis is based on its enteric toxin reduction platform technology termed "Enteric Dialysis®"

From Kibow Biotech Inc. 2 Aug 2019

Research reveals potential target for therapies to prevent severe allergic reactions

Allergies can be life-threatening when they cause anaphylaxis, an extreme reaction with constriction of the airways and a sudden drop in blood pressure.

2 Aug 2019

Trump administration ‘open for business’ on drug imports from Canada

A year after calling proposals allowing Americans to import cheaper drugs from Canada a "gimmick," Health and Human Services Secretary Alex Azar said the federal government is "open for business" on such a strategy.

31 Jul 2019

In a messy democratic presidential debate, facts about Medicare for all get tossed about

Here we go again. It's been a month since Democratic presidential hopefuls last took to the debate stage, but Tuesday night in Detroit 10 candidates again faced off for the first of this two-night event.

31 Jul 2019

FDA clears existing tests with new indications to aid in the diagnosis of Lyme disease

Today, the U.S. Food and Drug Administration cleared for marketing four previously cleared tests with new indications to aid in the diagnosis of Lyme disease.

30 Jul 2019

Study examines adherence of U.S. adults to physical activity guidelines

The proportion of U.S. adults adhering to the "Physical Activity Guidelines for Americans" from the U.S. Department of Health and Human Services didn't significantly improve between 2007 and 2016 but time spent sitting increased.

27 Jul 2019

FDA approves first nasal glucagon therapy for treatment of severe hypoglycemia

The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection.

24 Jul 2019

Summer setbacks: The long road to lower drug prices hits some potholes

When Washington returned from its winter holiday break in January, it seemed everyone was talking about lowering drug prices.

24 Jul 2019

Intensive glucose control not better than standard treatment of hyperglycemia, study finds

Hyperglycemia, or high levels of glucose, is common in patients with acute ischemic stroke and is associated with worse outcomes compared to normal blood sugar levels.

24 Jul 2019

Vaginal ring used by most women for HIV prevention in open-label study

In an open-label study of women in southern and eastern Africa, a vaginal ring that is inserted once a month and slowly releases an antiviral drug was estimated to reduce the risk of HIV by 39%, according to statistical modeling.

24 Jul 2019

Tailored adherence strategies needed to engage young African women in consistent PrEP use

In a study of open-label Truvada as daily pre-exposure prophylaxis (PrEP) to prevent HIV among 427 young African women and adolescent girls, 95% initiated the HIV prevention strategy, and most used PrEP for the first three months.

24 Jul 2019

NIH contract awarded to UAB for acute flaccid myelitis natural history study

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded the University of Alabama at Birmingham approximately $10 million over 5 years to study acute flaccid myelitis, a rare but serious condition which causes muscle weakness and paralysis.

23 Jul 2019

Researchers quantify smoking's strong connection with peripheral artery disease

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that cigarette smoking boosts the risk of peripheral artery disease, and this elevated risk can persist up to 30 years after smoking cessation.

23 Jul 2019

Health and Human Services News and Research

Study provides evidence that enterovirus may be a factor in acute flaccid myelitis

Women and older adults at increased risk of dangerous drug interactions

Class-action lawsuit seeks to let Medicare patients appeal gap in nursing home coverage

NIH-funded clinical trial will evaluate seasonal influenza vaccines with two experimental adjuvants

Statement related to data inaccuracies with newly approved gene therapy

Drugmakers now ‘masters’ at rolling out their own generics to stifle competition

FDA approves first therapy for symptomatic tenosynovial giant cell tumor

Company expands development plans for drugs which slow progression to dialysis

Research reveals potential target for therapies to prevent severe allergic reactions

Trump administration ‘open for business’ on drug imports from Canada

In a messy democratic presidential debate, facts about Medicare for all get tossed about

FDA clears existing tests with new indications to aid in the diagnosis of Lyme disease

Study examines adherence of U.S. adults to physical activity guidelines

FDA approves first nasal glucagon therapy for treatment of severe hypoglycemia

Summer setbacks: The long road to lower drug prices hits some potholes

Intensive glucose control not better than standard treatment of hyperglycemia, study finds

Vaginal ring used by most women for HIV prevention in open-label study

Tailored adherence strategies needed to engage young African women in consistent PrEP use

NIH contract awarded to UAB for acute flaccid myelitis natural history study

Researchers quantify smoking's strong connection with peripheral artery disease

Event guide: 6th Operationalize Expanded Access Programs Summit East eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News